DURECT Corporation (DRRX)
NASDAQ: DRRX · IEX Real-Time Price · USD
0.871
-0.039 (-4.26%)
At close: Apr 19, 2024, 4:00 PM
0.877
+0.006 (0.65%)
After-hours: Apr 19, 2024, 5:15 PM EDT
DURECT Market Cap
DURECT has a market cap or net worth of $27.04 million as of April 19, 2024. Its market cap has decreased by -74.56% in one year.
Market Cap
27.04M
Enterprise Value
18.10M
1-Year Change
-74.56%
Ranking
Category
Stock Price
$0.87
Market Cap Chart
Since September 28, 2000, DURECT's market cap has decreased from $660.10M to $27.04M, a decrease of -95.90%. That is a compound annual growth rate of -12.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2024 | 27.20M | 12.40% |
| Apr 16, 2024 | 24.20M | -2.02% |
| Apr 15, 2024 | 24.70M | 3.78% |
| Apr 12, 2024 | 23.80M | -6.30% |
| Apr 11, 2024 | 25.40M | -1.93% |
| Apr 10, 2024 | 25.90M | -1.15% |
| Apr 9, 2024 | 26.20M | -6.09% |
| Apr 8, 2024 | 27.90M | -3.46% |
| Apr 5, 2024 | 28.90M | -9.69% |
| Apr 4, 2024 | 32.00M | -10.36% |
| Apr 3, 2024 | 35.70M | 8.51% |
| Apr 2, 2024 | 32.90M | -4.36% |
| Apr 1, 2024 | 34.40M | -8.51% |
| Mar 28, 2024 | 37.60M | -6.00% |
| Mar 27, 2024 | 40.00M | 5.54% |
| Mar 26, 2024 | 37.90M | -0.79% |
| Mar 25, 2024 | 38.20M | 9.46% |
| Mar 22, 2024 | 34.90M | -6.43% |
| Mar 21, 2024 | 37.30M | -2.36% |
| Mar 20, 2024 | 38.20M | 8.52% |
| Mar 19, 2024 | 35.20M | -12.66% |
| Mar 18, 2024 | 40.30M | 4.68% |
| Mar 15, 2024 | 38.50M | -5.87% |
| Mar 14, 2024 | 40.90M | 21.36% |
| Mar 13, 2024 | 33.70M | -1.75% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 28.90M |
| Acasti Pharma | 28.86M |
| Spruce Biosciences | 28.85M |
| Singular Genomics Systems | 28.75M |
| Forte Biosciences | 28.39M |
| Lexaria Bioscience | 27.85M |
| Qilian International Holding Group | 27.53M |
| Serina Therapeutics | 27.34M |